Catalysis plays a vital role in pharmaceutical manufacturing by enabling highly selective, efficient, and reproducible synthesis of active pharmaceutical ingredients (APIs) and complex drug molecules. Modern catalytic processes help reduce production costs, improve product quality, and minimize environmental impact while meeting stringent regulatory standards. Continuous innovation in pharmaceutical catalysis supports the development of safer and more sustainable manufacturing methods.
Researchers are investigating asymmetric catalysis, organocatalysis, biocatalysis, transition metal catalysts, and continuous-flow synthesis to improve reaction efficiency and product selectivity. Green chemistry principles are increasingly integrated into pharmaceutical production through solvent reduction, waste minimization, and energy-efficient catalytic pathways. Automation and digital process control are also improving manufacturing consistency and scalability.
This session provides a platform for discussing catalyst development, pharmaceutical process engineering, regulatory considerations, continuous manufacturing, and sustainable drug production technologies. Participants will exchange knowledge on innovative catalytic strategies that advance pharmaceutical research while ensuring quality, safety, and environmental responsibility.